【摘要】为研究马链球菌马亚种IgG结合蛋白(EAG)免疫原性和保护力,评价其作为马链球菌疫苗抗原的价值。采用PCR法扩增马链球菌马亚种EAG基因,将测序正确的EAG扩增产物与原核表达载体pET-28a(+)连接构建重组质粒,对转化后的大肠杆菌进行诱导表达,用诱导纯化后的重组蛋白作免疫原免疫小鼠,分析重组蛋白免疫小鼠后的抗体水平及对小鼠的免疫保护力。结果表明,诱导后可得到26 kDa的EAG重组蛋白,且该蛋白可与该菌阳性血清发生特异性反应。间接ELISA检测免疫小鼠的抗体效价可达1∶8 100,重组蛋白免疫后对小鼠保护力可达90%。该结果表明,表达的EAG蛋白具有良好的抗原性,可有效提高小鼠的体液免疫水平及免疫保护力。
Prokaryotic expression and immunogenicity of IgG-binding protein of Streptococcus equi subspecies equi
【Abstract】To analyze the immunogenicity and protective ability of recombinant IgG-binding protein (EAG) of Streptococcus equi subspecies equi and to evaluate its value when used as equine vaccine antigen, EAG gene was amplified by PCR and inserted into pET-28a vector. The EAG recombinant proteins were expressed and purified to immune mice. The serum antibody and challenge protection were tested. The purified recombinant protein of EAG was 26 kDa, and the protein reacted specifically with positive serum of Streptococcus equi subspecies equi. The mice antibody level for EAG immunization group was 1:8 100. The immunological protection result showed that the protection rate of the EAG recombinant protein was 90%. The results suggested that the EAG protein has good immunogenicity and immunological protection, and it can effectively increase the humoral immune response and immunological protection of mice.
【Keywords】 Streptococcus equi subspecies equi; EAG protein; expression; immunogenicity analysis;
【Funds】 National Science and Technology Support Program (No. 2012BAD46B01);
Su LK, Lu CP. Extraction of M protein of Streptococcus equi subspecies equi ATCC35246strain. Anim Husb Vet Med, 2004, 36(1): 25–26(in Chinese).
Kang LC, Chen XH, Zhong FG, et al. Isolation and identification of Streptococcus equi and vaccine development. Heilongjiang Anim Sci Vet Med, 2013, (5): 109–111(in Chinese).
Jacobs AA, Goovaerts D, Nuijten PJ, et al. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi. Vet Rec, 2000, 147(20): 563–567.
Flock M, Jacobsson K, Frykberg L, et al. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Infect Immun, 2004, 72(6): 3228–3236.
Anzai T, Timoney JF, Kuwamoto Y, et al. In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Vet Microbiol, 1999, 67(4): 277–286.
Serhir B, Higgins R, Foiry B, et al. Detection of immunoglobulin-G-binding proteins in Streptococcus suis. J Gen Microbiol, 1993, 139(12): 2953–2958.
Godehardt AW, Hammerschmidt S, Frank R, et al. Binding ofα2-macroglobulin to GRAB(Protein G-relatedα2-macroglobulin-binding protein), an important virulence factor of group A Streptococci, is mediated by two charged motifs in theΔA region. Biochem J, 2004, 381(3): 877–885.
Valentin-Weigand P, Traore MY, Biobel H, et al. Role of cxe macroglobulin in phagocytosis of group A and C Streptococci. Fems Microbiol Lett, 1990, 70(3): 321–324.
Cunningham MW. Pathogenesis of group A Streptococcal infections. Clin Microbiol Rev, 2000, 13(3): 470–511.
Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen restricted to one host. J Med Microbiol, 2011, 60(9): 1231–1240.
Mérant C, Sheoran A, Timoney JF. Association of Streptococcus equi with equine monocytes. Vet Immunol Immunop, 2011, 143(1/2): 83–86.
Halimubieke HSM, Wulijiang HJK. Strangles and prevention and cure. Xinjiang Anim Husb, 2007, (4): 53–54(in Chinese).
Guo JK, Wang XJ. Adenitis equorum. Chin J Anim Husb Vet, 2013, (10): 16–18(in Chinese).
Newton R, Waller AS, King A. Investigation of suspected adverse reactions following strangles vaccination in horses. Vet Rec, 2005, 156(9): 291–292.
Robinson C, Heather Z, Slater J, et al. Vaccination with a live multi-gene deletion strain protects horses against virulent challenge with Streptococcus equi. Vaccine, 2015, 33(9): 1160–1167.
Harms C, Mapes S, Akana N, et al. Detection of modified-live equine intranasal vaccine pathogens in adult horses using quantitative PCR. Vet Rec, 2014, 175(20): 510–510.
Figueiredo L, Cadete A, Gonçalves LM, Corvo ML, Almeida AJ. Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems. Vaccine, 2012, 30(46): 6551–6558.
Florindoa HF, Panditb S, Goncalves LMD, et al. New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model. Vaccine, 2009, 27(8): 1230–1241.
Timoney JF, Artiushin SC, Boschwitz JS. Comparison of the sequences and functions of Streptococcus equi M-like proteins Se M and Sz PSe. Infect Immun, 1997, 65(9): 3600–3605.
Anzai T, Kuwamoto Y, Wada R, et al. Variation in the N-terminal region of an M-like protein of Streptococcus equi and evaluation of its potential as a tool in epidemiologic studies. Am J Vet Res, 2005, 66(12): 2167–2171.
Galán JE, Timoney JF. Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli. Infect Immun, 1987, 55(12): 3181–3187.
Timoney JF, Denegri R, Sheoran A, Forster N. Affects of N-terminal variation in the Se M protein of Streptococus equi on antibody and fibrinogen binding. Vaccine, 2010, 28(6): 1522–1527.
Lindmark H, Nilsson M, Guss B. Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference. Infect Immun, 2001, 69(5): 3159–3163.
Guss B, Flock M, Frykberg L, et al. Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection. PLo S Pathog, 2009, 5(9): e1000584, doi: 10. 1371/journal. ppat. 1000584.
Meehan M, Lewis MJ, Byrne C, et al. Localization of the equine Ig G-binding domain in the fibrinogen-binding protein(Fg BP)of Streptococcus equi subsp. equi. Microbiology, 2009, 155(8): 2583–2592.